PARLIAMENTARY WRITTEN QUESTION
Diabetes: Medical Treatments (7 June 2022)
Question Asked
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of Tirzepatide as a treatment for type two diabetes.
Asked by:
Navendu Mishra (Labour)
Asked by:
Navendu Mishra (Labour)
Answer
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based recommendations for the National Health Service on whether licenced medicines represent a clinically and cost-effective use of resources. NICE is currently appraising Tirzepatide for the treatment of type 2 diabetes through its technology appraisal programme and expects to publish final guidance in April 2023.
Answered by:
Edward Argar (Conservative)
16 June 2022
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.